Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
How to Handle Erythropoietin in Orthopedic Surgery
1
Zitationen
1
Autoren
2000
Jahr
Abstract
SUMMARY Erythropoietin has been shown in numerous studies to be effective in raising the preoperative hematocrit and reducing the need for allogeneic transfusion in major orthopedic surgery 1–4 . Erythropoietin may be as good as or better than preoperative autologous 5 donation. The safety profile seems well established. There are still a number of unresolved questions regarding its use. Many of these questions relate to the cost‐effectiveness of this treatment. Erythropoietin is not appropriate for universal use; however, at times it may be the best or even the only treatment option available.
Ähnliche Arbeiten
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 5.187 Zit.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 · 3.209 Zit.
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
2015 · 2.393 Zit.
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 2.044 Zit.
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
1987 · 2.019 Zit.